“Long-Term Evaluation of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis Refractory to Conventional Therapy”. Reumatismo, vol. 59, no. 1, Mar. 2007, pp. 50-56, https://doi.org/10.4081/reumatismo.2007.50.